James W. Rhee, M.D.
Dr. James W. Rhee is one of the emergency medicine physicians who are currently affiliated with Cedars-Sinai Marina del Rey Hospital. He received his medical degree from the University of Connecticut, School of Medicine, and completed his residency at the University of Chicago. The physician is certified in Medical Toxicology, as well as in Emergency Medicine, and has published a number of papers on the subject of the damages done by toxic poisoning. Dr. James W. Rhee has over 20 years of professional experience. Prior to practicing medicine in California, he had a medical license for Illinois. Dr. James W. Rhee had earned a Master of Science degree from Georgetown before he matriculated at the University of Connecticut School of Medicine. The medical specialist is a very accomplished scholar who has given numerous scientific presentations at national meetings and engaged many emergency medicine residents in meaningful scholarship. He is a gifted teacher who has won the highest award for teaching given by the emergency medicine residents to a single University of Chicago faculty member in his very first and second years as a faculty member. In 2010, Dr. James W. Rhee was part of a clinical trial known as the Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection.
- Blue Cross / Blue Shield
Education & Training
University of Connecticut School of Medicine
University of Chicago
John H. Stroger Hospital of Cook County
Memberships & Affiliations
Publications & Media
Induced hypothermia is underused after resuscitation from cardiac arrest: a current practice survey.
Abella, B. S., Rhee, J. W., Huang, K. N., Vanden Hoek, T. L., Becker, L. B.
Use of clonidine in the prevention and management of neonatal abstinence syndrome.
Leikin, J. B., Mackendrick, W. P., Maloney, G. E., Rhee, J. W., Farrell, E., Wahl, M., Kelly, K.
Intramuscular ophthalmic homatropine vs. atropine to prevent lethality in rates with dichlorvos poisoning.
Bryant, S.M., Wills, B.K., Rhee, J.W., Aks, S.E., Maloney, G.
Pretreating rats with parenteral ophthalmic antimuscarinic agents decreases mortality from lethal organophosphate poisoning.
Bryant, S.M., Rhee, J.W., Thompson, T.M., Aks, S.E.
Parenteral ophthalmic tropicamide or cyclopentolate protects rats from lethal organophosphate poisoning.
Bryant, S.M., Rhee, J.W., Thompson, T.M., Lu, J.J., Aks, S.E.